Danaher Corporation (0R2B.L)
USD 178.02
(-1.24%)
USD 178.02
(-1.24%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 17.66 Billion USD | -7.47% |
| 2022 | 19.08 Billion USD | -13.9% |
| 2021 | 22.16 Billion USD | 4.6% |
| 2020 | 21.19 Billion USD | -1.44% |
| 2019 | 21.5 Billion USD | 121.95% |
| 2018 | 9.68 Billion USD | -6.19% |
| 2017 | 10.32 Billion USD | 6.92% |
| 2016 | 9.65 Billion USD | -19.68% |
| 2015 | 12.02 Billion USD | 253.53% |
| 2014 | 3.4 Billion USD | -1.02% |
| 2013 | 3.43 Billion USD | -35.0% |
| 2012 | 5.28 Billion USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 16.32 Billion USD | -6.77% |
| 2024 Q2 | 17.5 Billion USD | 6.65% |
| 2024 Q1 | 16.41 Billion USD | -1.74% |
| 2023 Q2 | 18.28 Billion USD | 0.13% |
| 2023 FY | 16.7 Billion USD | -12.46% |
| 2023 Q4 | 16.7 Billion USD | -14.38% |
| 2023 Q1 | 18.26 Billion USD | -4.32% |
| 2023 Q3 | 19.51 Billion USD | 6.72% |
| 2022 Q4 | 19.08 Billion USD | 2.93% |
| 2022 FY | 19.08 Billion USD | -13.9% |
| 2022 Q3 | 18.54 Billion USD | -7.53% |
| 2022 Q2 | 20.05 Billion USD | -7.88% |
| 2022 Q1 | 21.76 Billion USD | -1.8% |
| 2021 Q1 | 21.24 Billion USD | -3.34% |
| 2021 FY | 22.16 Billion USD | 4.6% |
| 2021 Q3 | 23.59 Billion USD | 15.64% |
| 2021 Q4 | 22.16 Billion USD | -6.03% |
| 2021 Q2 | 20.4 Billion USD | -3.98% |
| 2020 Q1 | 23.59 Billion USD | 6.5% |
| 2020 Q3 | 22.74 Billion USD | -2.25% |
| 2020 FY | 21.19 Billion USD | -1.44% |
| 2020 Q4 | 21.97 Billion USD | -3.36% |
| 2020 Q2 | 23.26 Billion USD | -1.41% |
| 2019 Q1 | 10.25 Billion USD | 5.88% |
| 2019 FY | 21.5 Billion USD | 121.95% |
| 2019 Q4 | 22.15 Billion USD | 27.68% |
| 2019 Q3 | 17.35 Billion USD | 58.85% |
| 2019 Q2 | 10.92 Billion USD | 6.5% |
| 2018 Q4 | 9.68 Billion USD | -8.24% |
| 2018 Q2 | 11.14 Billion USD | 7.06% |
| 2018 Q1 | 10.41 Billion USD | 0.81% |
| 2018 FY | 9.68 Billion USD | -6.19% |
| 2018 Q3 | 10.55 Billion USD | -5.27% |
| 2017 Q2 | 11.42 Billion USD | 17.4% |
| 2017 FY | 10.32 Billion USD | 6.92% |
| 2017 Q1 | 9.72 Billion USD | 0.57% |
| 2017 Q3 | 10.72 Billion USD | -6.09% |
| 2017 Q4 | 10.32 Billion USD | -3.72% |
| 2016 Q1 | 12.19 Billion USD | 1.41% |
| 2016 FY | 9.65 Billion USD | -19.68% |
| 2016 Q3 | 7.5 Billion USD | -37.51% |
| 2016 Q4 | 9.67 Billion USD | 28.94% |
| 2016 Q2 | 12 Billion USD | -1.53% |
| 2015 Q4 | 12.02 Billion USD | 4.36% |
| 2015 Q1 | 3.05 Billion USD | -10.22% |
| 2015 Q3 | 11.52 Billion USD | 277.46% |
| 2015 Q2 | 3.05 Billion USD | -0.04% |
| 2015 FY | 12.02 Billion USD | 253.53% |
| 2014 Q4 | 3.4 Billion USD | 14.73% |
| 2014 Q3 | 2.96 Billion USD | -1.83% |
| 2014 Q2 | 3.02 Billion USD | -11.77% |
| 2014 Q1 | 3.42 Billion USD | -0.4% |
| 2014 FY | 3.4 Billion USD | -1.02% |
| 2013 FY | 3.43 Billion USD | -35.0% |
| 2013 Q1 | 4.4 Billion USD | -16.71% |
| 2013 Q4 | 3.43 Billion USD | -0.26% |
| 2013 Q2 | 4.1 Billion USD | -6.89% |
| 2013 Q3 | 3.44 Billion USD | -15.98% |
| 2012 Q4 | 5.28 Billion USD | 0.0% |
| 2012 FY | 5.28 Billion USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Phreesia, Inc. | 2.04 Million USD | -861832.65% |
| Accuray Incorporated | 164.4 Million USD | -10642.701% |
| Align Technology, Inc. | 96.96 Million USD | -18113.225% |
| Elevance Health Inc. | 23.24 Billion USD | 24.026% |
| AxoGen, Inc. | 46.6 Million USD | -37796.702% |
| Boston Scientific Corporation | 8.56 Billion USD | -106.176% |
| CVS Health Corporation | 74.67 Billion USD | 76.349% |
| Cardinal Health, Inc. | 4.58 Billion USD | -285.359% |
| Centene Corporation | 17.69 Billion USD | 0.215% |
| DaVita Inc. | 8.05 Billion USD | -119.357% |
| HCA Healthcare, Inc. | 36.62 Billion USD | 51.783% |
| Hologic, Inc. | 2.49 Billion USD | -607.26% |
| Humana Inc. | 10.21 Billion USD | -72.927% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | -2735.364% |
| Laboratory Corporation of America Holdings | 4.05 Billion USD | -335.569% |
| Masimo Corporation | 871.7 Million USD | -1926.041% |
| McKesson Corporation | 5.45 Billion USD | -223.996% |
| Patterson Companies, Inc. | 328.91 Million USD | -5269.538% |
| Quest Diagnostics Incorporated | 4.41 Billion USD | -300.476% |
| ResMed Inc. | 697.31 Million USD | -2432.722% |
| Henry Schein, Inc. | 1.93 Billion USD | -813.658% |
| Teladoc Health, Inc. | 1.58 Billion USD | -1016.707% |
| Universal Health Services, Inc. | 4.71 Billion USD | -274.48% |
| Veeva Systems Inc. | 46.44 Million USD | -37928.897% |
| Baxter International Inc. | 11.06 Billion USD | -59.626% |
| Becton, Dickinson and Company | 14.73 Billion USD | -19.833% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 21611.571% |
| Stryker Corporation | 10.9 Billion USD | -62.013% |
| Medtronic plc | 23.87 Billion USD | 26.033% |